These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11186514)

  • 21. Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005.
    Song HK; Diggs BS; Slater MS; Guyton SW; Ungerleider RM; Welke KF
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):65-9. PubMed ID: 19154905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
    von der Schulenburg J; Vauth C; Mittendorf T; Greiner W
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marketplace. Assessing medical innovations: how health plans pick what technology to cover.
    Moskowitz DB
    Faulkner Grays Med Health; 1997 May; 51(21):suppl 2 p.. PubMed ID: 10167124
    [No Abstract]   [Full Text] [Related]  

  • 24. Value of cost-benefit analysis in health care field questioned.
    Am Med News; 1980 Aug; 23(33):1. PubMed ID: 10309251
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost effectiveness as a criterion for Medicare coverage.
    Leaf A
    N Engl J Med; 1989 Sep; 321(13):898-900. PubMed ID: 2505078
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
    Gray DT; Veenstra DL
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):618-24. PubMed ID: 12658204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using cost-effectiveness and cost-benefit analysis for health care policy making.
    Kristen MM
    Adv Health Econ Health Serv Res; 1983; 4():199-224. PubMed ID: 10310507
    [No Abstract]   [Full Text] [Related]  

  • 28. Life-cycle management: a long-term challenge.
    Newman C
    Med Device Technol; 2003 Apr; 14(3):32-3. PubMed ID: 12789698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward rational technology in medicine: considerations for health policy.
    Banta HD; Behney CJ; Willems JS
    Springer Ser Health Care Soc; 1981; 5():v-xiv, 1-242. PubMed ID: 10309422
    [No Abstract]   [Full Text] [Related]  

  • 30. Using methods developed to assess drugs, a few institutions lead in weighing value of new technologies and procedures.
    Southwick K
    Strateg Healthc Excell; 1997 Jun; 10(6):1-10. PubMed ID: 10167811
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-effectiveness analysis as a measure of value.
    Garber AM
    Tecnologica; 1996 Jan; ():1, 3-6, 9-10. PubMed ID: 10170483
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confluence of ethical and economic issues in the development and adoption of high technology approaches in clinical care.
    Keller KH
    Trends Health Care Law Ethics; 1992; 7(3-4):19-28. PubMed ID: 11651471
    [No Abstract]   [Full Text] [Related]  

  • 34. Setting priorities in and for end-of-life care: challenges in the application of economic evaluation.
    Normand C
    Health Econ Policy Law; 2012 Oct; 7(4):431-9. PubMed ID: 23079301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethical models for health management.
    Eijk WJ
    Dolentium Hominum; 1998; No. 37 yr. 13(1):58-62. PubMed ID: 11657198
    [No Abstract]   [Full Text] [Related]  

  • 36. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical innovations and ethics: a state government perspective.
    Swidler RN
    Albany Law Rev; 1994; 57(3):655-77. PubMed ID: 11652859
    [No Abstract]   [Full Text] [Related]  

  • 38. Does assessment of medical practices have a future?
    Capron AM
    Va Law Rev; 1996 Nov; 82(8):1623-40. PubMed ID: 16715566
    [No Abstract]   [Full Text] [Related]  

  • 39. The value of coronary heart disease care for the elderly: 1987-2002.
    Rosen AB; Cutler DM; Norton DM; Hu HM; Vijan S
    Health Aff (Millwood); 2007; 26(1):111-23. PubMed ID: 17211020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Getting down to the numbers. Can the value of health care really be quantified?
    Walker LM
    State Health Care Am; 2001; ():55-8. PubMed ID: 11521326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.